Literature DB >> 10728156

Frequency of recovery from anorexia nervosa of a cohort patients re-evaluated on a long-term basis following intensive care.

L Foppiani1, L Luise, E Rasore, U Menichini, M Giusti.   

Abstract

The need to treat the acute onset of anorexia nervosa in a specialty unit is well known, but nevertheless, even "clinically recovered" patients show a high rate of relapse. The aim of our study was to re-evaluate various clinical (hemoglobin, transferrin, insulin-like growth factor I, TSH, PRL, gonadotropins and 17 beta-estradiol) and psychiatric [semistructured interview, Eating Disorder Inventory (EDI) Test] parameters in 19 female anorexic patients hospitalized in our department from 1983 to 1993 (with a 9-year median prior to the present study) for the treatment of anorexia nervosa, and to compare these results with those of a previous follow-up performed on the same subjects in 1993. In the present evaluation, no significant variation was found among the clinical, nutritional and hormonal parameters when compared to those of the first follow-up in which all parameters had improved with the exception of the PRL levels, which were significantly low. Meanwhile, the percentage of patients with spontaneous menses increased significantly from 50% to 70%, while the number of patients on psychopharmacological therapy decreased significantly throughout the study. Furthermore the percentage of patients with altered (severe or mild) EDI profiles decreased to 50%. This study emphasizes the positive prognostic role of hospitalization and intensive care in a cohort of anorexic patients. The present study, in addition to demonstrating both a general maintenance of body weight acquired over the years, albeit in the lower normal range, and an increase in the percentage of patients with a regular menstrual cycle, also highlights the persistence of psychiatric abnormalities in a large number of patients, even in those diagnosed as "clinically recovered", thus suggesting the need for long-term psychiatric care.

Entities:  

Mesh:

Year:  1998        PMID: 10728156     DOI: 10.1007/bf03339994

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  16 in total

1.  Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa.

Authors:  M Giusti; L Foppiani; P Ponzani; C M Cuttica; M R Falivene; S Valenti
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  Outcome and prognosis of anorexia nervosa. A retrospective study of 41 subjects.

Authors:  J H Rosenvinge; S O Mouland
Journal:  Br J Psychiatry       Date:  1990-01       Impact factor: 9.319

Review 3.  Comorbidity and outcome in eating disorders.

Authors:  D B Herzog; K M Nussbaum; A K Marmor
Journal:  Psychiatr Clin North Am       Date:  1996-12

4.  Ten-year follow-up of anorexia nervosa: clinical course and outcome.

Authors:  E D Eckert; K A Halmi; P Marchi; W Grove; R Crosby
Journal:  Psychol Med       Date:  1995-01       Impact factor: 7.723

5.  The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.

Authors:  M Hotta; T Shibasaki; A Masuda; T Imaki; H Demura; N Ling; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

6.  Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: influence of weight recovery.

Authors:  K Kiyohara; H Tamai; Y Takaichi; T Nakagawa; L F Kumagai
Journal:  Am J Clin Nutr       Date:  1989-10       Impact factor: 7.045

7.  [Anorexia nervosa: a follow-up of nutritional, hormonal and psychiatric parameters].

Authors:  L Foppiani; V Uva; M Falivene; S Valenti; C Traversa; E Rasore; M Giusti
Journal:  Minerva Med       Date:  1995-12       Impact factor: 4.806

8.  Alternate-day GnRH therapy for ovarian hypofunction induced by weight loss: treatment of six patients who remained amenorrhoeic after weight gain.

Authors:  F Kotsuji; M Kubo; Y Takeuchi; T Tominaga
Journal:  Clin Endocrinol (Oxf)       Date:  1993-12       Impact factor: 3.478

9.  Endogenous opioid blockade and gonadotropin secretion: role of pulsatile luteinizing hormone-releasing hormone administration in anorexia nervosa and weight loss amenorrhea.

Authors:  M Giusti; R Torre; L Traverso; P Cavagnaro; R Attanasio; G Giordano
Journal:  Fertil Steril       Date:  1988-05       Impact factor: 7.329

10.  Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia.

Authors:  P Bouchard; M Lagoguey; S Brailly; G Schaison
Journal:  J Clin Endocrinol Metab       Date:  1985-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.